InsidersTradesSigma
argenx SE: management transactions · Netherlands · AFM
AFM:argenx-seNL·AFMMcap 50.0Bn€Healthcare & Pharma
Browse the full management transaction log of argenx SE, a listed issuer based in Netherlands. Shares trade on NL NL, under the supervision of AFM. Operating in the Healthcare & Pharma sector, argenx SE has recorded 253 insider filings. Market capitalisation: €50bn. The latest transaction was disclosed on 6 May 2026 — Mixed. Among the most active insiders: T.J.M. van Hauwermeiren. All data is openly available.
253
Insider Decl.
0
Thresholds
€175,418
68 ops.
Buy Volume
€36m
57 ops.
Sell Volume
Financial data
Analyst consensus
22 analystsStrong buy
691.70 €Target 1022.11 €1245.05 €
Valuation
PER (trailing)35.5x
PER (forward)25.6x
P/Book168.9x
Beta-0.06
Balance sheet & cash
Market cap49.95 Bn€
Debt / Equity1%
Profitability & ownership
% insiders0.0%
% institutions47.4%
Last declaration on 6 May 2026
Declarations253 total
Executives●Mixed13AFM
0-9,847 shares0
Restricted Stock Unit
AFM:193107·
Executives●Mixed13AFM
0-132 shares0
Restricted Stock Unit
AFM:191191·
Executives●Sale15AFM
€70,662-107 shares@ €660.390.0001% mcap23.2% of flow
Gewoon aandeel
AFM:188922·
Executives●Other14AFM
€1m0@ €270.200.0028% mcap9.3% of flow
Personeelsoptie
AFM:188811·
Executives●Mixed15AFM
€6m-65,000 shares@ €43.160.011% mcap12.6% of flow
Personeelsoptie
AFM:188266·
Executives●Mixed13AFM
0-1,425 shares0
Restricted Stock Unit
AFM:185363·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185360·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185361·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185358·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185293·
Executives●Mixed13AFM
0-225 shares0
Restricted Stock Unit
AFM:185295·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185300·
Executives●Mixed13AFM
0-150 shares0
Restricted Stock Unit
AFM:185292·
Executives●Mixed13AFM
0-1,425 shares0
Restricted Stock Unit
AFM:185294·
Executives●Other14AFM
€2m0@ €261.790.0031% mcap11.1% of flow
Personeelsoptie
AFM:184246·
Executives●Sale13AFM
€37,806-48.24 shares@ €783.700.0001% mcap0.1% of flow
Gewoon aandeel
AFM:183935·
Executives●Sale13AFM
€38,447-48.24 shares@ €797.000.0001% mcap0.1% of flow
Gewoon aandeel
AFM:183751·
Executives●Other17AFM
€4m0@ €273.070.0077% mcap25.1% of flow
Personeelsoptie
AFM:183692·
Executives●Sale13AFM
€37,048-48.24 shares@ €768.000.0001% mcap0.1% of flow
Gewoon aandeel
AFM:183359·
Executives●Mixed13AFM
0-225 shares0
Restricted Stock Unit
AFM:181422·
25 of 253 declarations
About argenx SE
argenx SE is a biopharmaceutical company focused on developing therapeutic antibodies for treating autoimmune diseases and cancers. It is listed on the Euronext Amsterdam market.
